PATENT CLAIM ANALYSIS

Application Number: 15745789
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["514", "655000"]

Abstract:
Methods for increasing susceptibility of cancer cells to immunotherapeutic agents and methods for assessing the effectiveness of a cancer treatment.

Claim (Index 25):
A kit to carry out the method as defined in  claim 22 , comprising appropriate means to quantify the expression level of:\n a CTA of the SSX family selected from SSX 4 and/or SSX 4B; and a CTA of the GAGE family selected from the group consisting of GAGE1, GAGE 2A, GAGE 2B, GAGE 2C, GAGE 2D, GAGE 2E, GAGE 4, GAGE 5, GAGE 6, GAGE 7, GAGE 8, GAGE 10, GAGE 12B, GAGE 12C, GAGE 12D, GAGE 12E, GAGE 12F, GAGE 12G, GAGE 12H, GAGE 12I, GAGE 12J, GAGE 13 and combinations thereof; and optionally a CTA of the MAGE family selected from MAGE A2 and/or MAGE A3, and/or a non-X-CTA, and a suitable packaging.

Metadata:
- Claim Count in Document: 7.0
- Percentile: 86.0
- Lexical Diversity: 1.16667
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['10485351', '15616672', '14926372', '14346693', '15253307']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7254388748194187
- 35 USC 102 Novelty (BERT): 0.5048968602028663
- Combined Prediction Score: 0.7033846733577634
- Mean Citation Score: 195.007452
- Max Citation Score: 224.70102000000003
- Similarity Product: 140.04724285039188

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test